
Conference Coverage
about 2 hours ago
Overcoming Barriers to Kidney-Protective TherapyLatest News
Shorts










Continuing Education
All News

Decode carcinogens: IARC hazard vs risk, what "possibly" means, and how pharmacists ease aspartame, meat, and phone fears.

FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth
Garetosmab-grts cut new heterotopic ossification lesions by 90% or more at 56 weeks in the phase 3 OPTIMA trial.

Intismeran autogene plus pembrolizumab significantly improved recurrence-free and distant metastasis-free survival over pembrolizumab alone.

Findings published in Lancet Child & Adolescent Health arrive as a new US executive order shifts rotavirus vaccination to shared clinical decision-making.

The patch detected fentanyl and automatically delivered dose-responsive naloxone in laboratory and mouse studies, offering a potential strategy for addressing unwitnessed opioid overdoses.

New data link T2DM and prediabetes to more numerous, more severe symptoms, especially postmenopause.

Learn how common meds, immunosuppressants, steroids, anti-CD20 biologics, and antivirals change vaccine timing for the best.

Beyond financial considerations, the emotional meaning of retirement is an often-forgotten question.

A nationally representative analysis found serologic immunity to hepatitis A and B was limited among US adults, including populations at elevated risk.

In an interview with Pharmacy Times, Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, discussed how Inlexzo and increasingly complex urologic cancer therapies are driving closer coordination between urology and oncology pharmacy.

New ACC statement urges pharmacists to weigh cognition and frailty in every older adult's cardiovascular regimen.

Without an identifiable cure, pharmacists must prioritize prompt diagnosis and individualized symptom management.

The bill raises broader questions about pharmacist recognition as frontline care providers—not mere medication dispensers.

First-line trastuzumab deruxtecan significantly delayed disease progression in HER2-mutant advanced NSCLC.

Adding family-based behavioral treatment to standard care nearly doubled clinically meaningful weight loss in kids in the TEAM UP trial.

The all-oral combination of osimertinib and savolitinib significantly improved progression-free and overall survival following osimertinib resistance.

Topiramate, an antiseizure medication, has an off-label indication for cocaine use disorder and it received a conditional recommendation with a low certainty of evidence.

The agency's decision pairs a new self-administration device with label language tying LDL-C lowering to cardiovascular outcomes.

New research shows COVID vaccine hesitancy wanes, but burnout rises.

Every diagnosis comes with a workload for patients.

From patient selection to prior authorization: Tim Pflederer, MD, on delivering guideline-directed CKD care beyond the 15-minute visit.

Amid 2026 vaccine schedule changes, Trump executive order and vaccines spark confusion—see what’s legal, why AAP guides the childhood vaccine schedule.

The approval is supported by clinical data from 2 studies.







































